Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

December 30, 2024

Conditions
Bronchial Cancer
Trial Locations (1)

29609

CHU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER